San Francisco-based AliveCor has received FDA clearance for two new algorithms for its smartphone-connected ECG: one that detects normality and one that detects interference. These follow up on ...

Smartphone-enabled heart monitor device maker AliveCor has launched a new app for patients, which is both timed with the new iOS 8 launch and incorporates the atrial fibrillation algorithm the company ...

The CDC estimates that 2.5% of the US population—over 8 million people—suffer from valvular heart disease, in which one or more of the heart’s four valves is damaged or diseased. According to the ...

This review article presents a three-part true-life clinical vignette that illustrates how digital health technology can aid providers caring for patients with cardiovascular disease. Specific ...

KYOTO, Japan, Apr 2, 2026 - (JCN Newswire) - OMRON Healthcare Co., Ltd. today announced the launch of a randomized controlled trial in collaboration with the University of California, San Francisco ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Tailored ablation guided by AI better prevented atrial ...

Despite guideline recommendations, evidence for the use of non–vitamin K antagonist oral anticoagulant (NOAC) monotherapy in patients with atrial fibrillation after implantation of a drug-eluting ...